Vij, R., Le-Rademacher, J., Laumann, K., Hars, V., Owzar, K., Shore, T., . . . Devine, S. (2019). A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acute myeloid leukemia: CALGB 100801 (Alliance). Biol Blood Marrow Transplant.
শিকাগো স্টাইলে সাইটেশনVij, Ravi, et al. "A Phase II Multi-center Study of the Addition of Azacitidine to Reduced-intensity Conditioning Allogeneic Transplantation for High-risk Myelodysplasia (and Older Patients With Acute Myeloid Leukemia: CALGB 100801 (Alliance)." Biol Blood Marrow Transplant 2019.
এমএলএ সাইটেশনVij, Ravi, et al. "A Phase II Multi-center Study of the Addition of Azacitidine to Reduced-intensity Conditioning Allogeneic Transplantation for High-risk Myelodysplasia (and Older Patients With Acute Myeloid Leukemia: CALGB 100801 (Alliance)." Biol Blood Marrow Transplant 2019.